Skip to main content
. 2011 Nov 23;4:79. doi: 10.1186/1755-8794-4-79

Table 4.

Prediction for chemoresistance in the proof-of-principle test set

Sample ID Feature selection P < 0.05 Feature selection P < 0.01
Predictive
Index
Percentile1
Prediction
For
Pretreatment
Sample2
Overall
Prediction3
Predictive
Index
Percentile
Prediction
for
Pretreatment
Sample
Overall
Prediction
1 pre 39% low incorrect 35% low incorrect
1 post 22% 24%
2 pre 48% low correct 49% low correct
2 post 79% 77%
3 pre 55% low correct 46% low correct
3 post 73% 77%
4 pre 13% low correct 24% low correct
4 post 72% 73%
5 pre 31% low correct 33% low correct
5 post 48% 46%
6 pre 13% low correct 27% low correct
6 post 16% 66%
7 pre 7% low correct 12% low correct
7 post 66% 57%
8 pre 52% low incorrect 50% low incorrect
8 post 17% 24%

1The predictive index was computed for each sample by this supervised principal component method, where a high value of the predictive index corresponds to a rapid progression after chemotherapy (i.e., short TTP). If the predictive index of a sample in the test set corresponded to the median predictive index of the training set, the sample was assigned a 50% predictive index.

2The risk was predicted low, if predictive index percentile of the pretreatment sample was less than 67%

3The prediction was considered correct if post-treatment samples were assigned a higher predictive index than pre-treatment samples.